Focus: Geron is an oncology-focused biotechnology company based in Foster City, CA, specializing in small-molecule telomerase inhibitors for hematologic malignancies and solid tumors.
Profile data last refreshed 21m ago · AI intelligence enriched 3w ago
Stable — net -4 jobs in 30d
3 added, 7 removed. Backfill posture.
Best fit for oncology scientists and clinical professionals seeking exposure to a novel MOA with near-term revenue validation, but accept execution risk on pipeline breadth.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Geron
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Geron's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
First approved telomerase inhibitor providing 14+ years of LOE protection and serving as company anchor.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles